Key Takeaways
- EnoviQ’s CLAPi© has received two separate Celent XCelent recognitions: Luminary in 2022 (Global Health Policy Administration) and Functionality Standout in 2025 (Global P&C Policy Administration).
- CLAPi© is the only InsurTech platform to have received Celent recognition across both Health and P&C Policy Administration Systems — confirming its position as a genuinely unified, multi-LOB platform.
- The 2022 Luminary award recognised CLAPi© as top-rated in both Advanced Technology and Breadth of Functionality among 25 Global Health platforms evaluated.
- The 2025 Functionality Standout confirms CLAPi© has maintained and extended its capabilities into P&C — three years after the first award.
- EnoviQ is also ISO Certified and SOC2 attested— providing independent assurance of platform security, quality, and operational integrity.
When an insurance technology vendor wins a single analyst award, it is a noteworthy milestone. When the same vendor’s platform wins recognition from the same analyst firm across two different lines of business, three years apart, it signals something more significant: a platform that has not only achieved high standards in one area, but has consistently invested in and extended its capabilities across the full insurance spectrum.
EnoviQ’s CLAPi© is that platform. In 2022, Celent recognised CLAPi© as a Luminary in Global Health Policy Administration Systems — the highest designation, awarded to solutions excelling simultaneously in Advanced Technology and Breadth of Functionality. In 2025, Celent recognised CLAPi© again, this time as a Functionality Standout in Global P&C Policy Administration Systems.
No other InsurTech platform of CLAPi©’s scale has received Celent recognition across both Health and P&C Policy Administration in consecutive evaluation cycles. This article explains what each award means, what Celent evaluated, and why this dual recognition matters for an insurer choosing a long-term technology partner.
About Celent’s XCelent Evaluation
Celent is a global financial services research and advisory firm. Its XCelent Awards are not sponsored recognitions or paid-for certifications — they are the result of rigorous vendor evaluation conducted by Celent analysts on behalf of financial institutions that use Celent’s research to make technology decisions.
The Global Health Policy Administration Systems and Global P&C Policy Administration Systems evaluations assess platforms across multiple dimensions including Advanced Technology (platform architecture, cloud-native design, API capability, scalability), Breadth of Functionality (range and depth of insurance functions covered), and Customer Base (live deployments, geographic coverage, client retention).
The designations awarded — Luminary, Functionality Standout, Technology Standout — represent objective analyst judgments, not vendor self-assessment. For insurers conducting platform due diligence, Celent recognition provides a third-party validation that complements internal evaluation criteria.
The Two CLAPi© Celent Recognitions
Global Health Policy Administration Systems — XCelent Award
Top solution among 25 global platforms evaluated. Named Luminary in both Advanced Technology AND Breadth of Functionality simultaneously — the highest Celent designation. Recognised for exceptional cloud-native architecture, API-first design, and comprehensive Health insurance module coverage. Announced February 2023.
Global P&C Policy Administration Systems — XCelent Award
Recognised for outstanding breadth and depth of P&C insurance platform functionality. Confirms CLAPi©'s expansion beyond Health into P&C — validating the platform's unified multi-LOB capability covering A&H, Life and P&C on a single cloud-native core. Featured in Celent's Technical Capability Matrix.
Why Two Awards Across Health and P&C Matter
The significance of these two recognitions is not simply additive — it reflects a fundamental characteristic of CLAPi©’s architecture. CLAPi© is explicitly positioned as “The Only Unified InsurTech Platform Covering A&H, Life & P&C — One Platform. Every Insurer. Anywhere.”
Most insurance technology vendors specialise in one line of business. Health platforms are built for health insurers. P&C platforms are built for General insurers. The operational requirements differ enough that building deep capability in both on a single platform is genuinely difficult — and rarely achieved.
CLAPi©’s Celent recognition in both Health (2022) and P&C (2025) is independent, analyst-validated evidence that the platform has achieved this depth across both LOBs. For an insurer operating across Health and P&C — or planning to expand from one to the other — this dual recognition is directly relevant to the platform selection decision.
As Avi Raju, Managing Director of EnoviQ, stated at the time of the 2022 award: “Celent not only recognised the advanced technology of our platform, but also identified the excellent and wide functionality of our platform. This is a testament of our strong team of deep domain experts.”
What Celent Specifically Evaluated in CLAPi©
-
Advanced Technology — 2022 Health Evaluation
The 2022 Luminary’s Advanced Technology recognition evaluated CLAPi©’s technical architecture: microservices design, Docker containerisation, Kubernetes orchestration, serverless functions, immutable infrastructure deployed via declarative code, Jenkins CI/CD pipeline, and SonarQube code quality controls. This is the architecture that enables CLAPi©’s zero-downtime deployment, independent module scaling, and API-first distribution capability — all characteristics Celent defines as advanced technology in insurance platform evaluation.
-
Breadth of Functionality — Both Evaluations
CLAPi©’s eight core modules — Product Workspace, Rule Engine, Entity Management, Policy Administration, Policy Accounting, Claims Management / TPA, Provider Management, and Reinsurance — plus eight add-on modules covering Employee Benefit Portal, Customer Portal, Partner & Provider Portal, Business Reporting, Document Management, and Audit & Investigation — provide the breadth of functionality that Celent evaluates across both Health and P&C assessment cycles.
This breadth of LOB coverage — across both A&H and P&C — is directly reflected in Celent’s evaluation of the platform’s functional depth in both 2022 and 2025.
EnoviQ’s Security and Compliance Credentials
Celent’s recognition of CLAPi©’s technical architecture is supported by independent security and compliance certifications that confirm the platform’s operational integrity for insurance deployments:
International quality management standard — confirms EnoviQ's processes meet global quality benchmarks for software development and service delivery.
Service Organisation Control 2 certification — independent audit confirming CLAPi©'s security, availability, processing integrity, confidentiality, and privacy controls.
For insurance companies selecting a core platform, ISO and SOC2 certification are baseline requirements in most APAC procurement frameworks. MAS-regulated insurers in Singapore, IRDAI-regulated insurers in India, and IA-regulated insurers in Hong Kong all operate under regulatory expectations that their core technology partners maintain recognised security and quality standards. CLAPi©’s dual certification meets these expectations.
What This Track Record Means for Insurers Evaluating a Platform in 2026
Insurance platform selection is a decision with a ten-to-fifteen-year horizon. The insurer is not choosing software for next year — it is choosing a technology partner for the better part of a decade. In that context, a vendor’s track record of consistent investment, capability improvement, and third-party validation matters more than any single product demonstration.
CLAPi©’s progression from Celent Luminary in 2022 to Functionality Standout in 2025 — across two different lines of business — is a three-year track record of exactly this kind of consistent investment. The platform that earned Celent’s highest designation in Health administration in 2022 has, by 2025, extended that capability sufficiently to earn independent recognition in P&C as well.
For a CTO or CIO conducting a platform evaluation, this trajectory is a meaningful data point: EnoviQ is a vendor that invests in its platform, extends its capabilities, and earns independent validation of both.
EnoviQ serves 10+ insurance clients across Asia Pacific, including HSBC, AXA, Narayana Health, Tune Protect, AAR Insurance, and Strategis Insurance, from regional offices in Singapore, Hong Kong, and India — with a team of 150+ dedicated InsurTech professionals.
FAQs
The Celent XCelent Award is given by Celent — a global financial services research and advisory firm — to insurance technology platforms that achieve standout performance in its annual vendor evaluation reports. Awards are given across categories including Advanced Technology, Breadth of Functionality, and Customer Base. Celent evaluations are independent — they are not paid recognitions or sponsored awards.
The Celent Luminary designation is awarded to platforms that achieve standout performance simultaneously in both Advanced Technology and Breadth of Functionality — it is the highest designation in Celent’s Technical Capability Matrix. CLAPi© received the Luminary designation in the 2022 Global Health Policy Administration Systems evaluation, recognising it as the top solution among 25 global platforms assessed.
CLAPi© has received Celent recognition across two lines of business: Global Health Policy Administration Systems (2022 — Luminary designation) and Global P&C Policy Administration Systems (2025 — Functionality Standout designation). This makes CLAPi© one of very few InsurTech platforms to have received independent Celent recognition across both Health and P&C in consecutive evaluation cycles.
Celent Luminary is the highest designation, awarded to platforms that excel in both Advanced Technology and Breadth of Functionality simultaneously. Functionality Standout is awarded to platforms that demonstrate outstanding breadth and depth of functionality in a specific area. Both are independent analyst recognitions that reflect platform performance in Celent’s rigorous evaluation methodology.
Yes. EnoviQ is both ISO certified and SOC2 attested. ISO certification confirms that EnoviQ’s processes meet international quality management standards for software development and service delivery. SOC2 certification is an independent audit confirming CLAPi©’s security, availability, processing integrity, confidentiality, and privacy controls — directly relevant for insurers operating under APAC regulatory frameworks that require technology partners to meet recognised security standards.
Evaluate the Celent-Recognised Platform for Your Insurance Operation
If you are evaluating insurance policy administration platforms and want to see the capabilities that earned CLAPi© Celent’s recognition across both Health and P&C, our team can walk you through a live demonstration tailored to your specific LOB and market requirements.
